Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Total Debt Over TimeNormalizing
Percentile Rank50
3Y CAGR-17.4%
5Y CAGR+38.9%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
-17.4%/yr
Annual compound
5Y CAGR
+38.9%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
5.2x
Strong expansion
Streak
3 yr
Consecutive declineNormalizing
PeriodValueYoY Change
2025$10.94M-23.8%
2024$14.35M-15.1%
2023$16.91M-13.0%
2022$19.45M+1017.1%
2021$1.74M-17.7%
2020$2.12M-72.9%
2019$7.82M-